🇺🇸 FDA
Patent

US 9533031

Yeast-MUC1 immunotherapeutic compositions and uses thereof

granted A61KA61K2039/523A61K2039/525

Quick answer

US patent 9533031 (Yeast-MUC1 immunotherapeutic compositions and uses thereof) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/523, A61K2039/525, A61K2039/6031, A61K31/65